Biobank Collecting Samples and Records From People With Lung Scarring Diseases
Collects samples and health records from adults with interstitial lung disease to study it.
Key facts
- Who runs it
- University of Kansas Medical Center
- Where
- Kansas City, United StatesSee the site
- Trial code
- Registry title
- Interstitial Lung Disease Research Unit Biobank
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 9 Aug 2021
- Expected to end
- 1 Mar 2032
- Type of study
- Observational
- Record updated
- 10 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults followed at TUKHS for an autoimmune disease, interstitial lung disease or another rare lung disease. It builds a registry and sample bank to study these diseases.
- Age
- 18 years or older
- Sex
- All sexes can join.
Main reasons for not taking part
- Not a patient at TUKHS and not in another study approved by the KUMC Human Research Protection Program
- Not being followed at TUKHS for autoimmune disease, ILD or other rare lung diseases
- Has not signed the approved consent for this study (living patients only)
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
- The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS
- The participant is ≥ 18 years of age
- The participant has signed an approved consent for this study (living patients only)
Where in United States
- The University of Kansas Medical CenterKansas City, United StatesContact: Kimberly Donnelly, Ph.D.Taking people
About the trial
What the trial wants to find out
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank
- Plain-language title
- Biobank Collecting Samples and Records From People With Lung Scarring DiseasesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 July 2026